Enantioselective high-performance liquid chromatographic method for the determination of baclofen in human plasma

Talanta

Volumn 61, Issue 5, 2003, Pages 667-673

  Hefnawy, Mohamed M ^a   Aboul Enein, Hassan Y ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Baclofen; Enantioseparation; Human plasma; Teicoplanin chiral stationary phase

Indexed keywords

ACETIC ACID; EXTRACTION; METHANOL; STEREOCHEMISTRY; ULTRAVIOLET DETECTORS;

ENANTIOMERS;

BODY FLUIDS;

ACETIC ACID; BACLOFEN; ETHER; MACROCYCLIC COMPOUND; SULPIRIDE; TEICOPLANIN; TRIETHYLAMINE;

ARTICLE; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; ENANTIOMER; ENANTIOSELECTIVITY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID LIQUID EXTRACTION; MATHEMATICAL COMPUTING; STRUCTURE ANALYSIS; ULTRAVIOLET RADIATION;

EID: 0242413841     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-9140(03)00352-7     Document Type: Article

References (28)

1. A. Scott, Drug Saf. 8 (1993) 149-159.
2. R. Nation, Clin. Pharmacokinet. 27 (1994) 249-255.
3. H.Y. Aboul-Enein, L.I. Abou-Basha, Chirality and drug hazards (Chapter 1), in: H.Y. Aboul-Enein, I.W. Wainer (Eds.), The Impact of Stereochemistry on Drug Development and Use, Wiley, 1997, pp. 1-19.
4. J.S. Oleksiak, J. Bojarski, H.Y. Aboul-Enein, Chirality 14 (2002) 417-435.
5. M. Islam, J. Mahdi, I. Bowen, Drug Saf. 17 (1997) 149-165.
6. H.Y. Aboul-Enein, I. Ali, Chromatographia 52 (2000) 679-691.
7. T. Rojkovicova, J. Lehotay, J. Dungelova, J. Cizmarik, D.W. Armstrong, J. Liq. Chromatogr. Rel. Tech. 25 (2002) 2723-2738.
8. D.W. Armstrong, Y. Tan, S. Chen, Y. Zhou, C. Gagwill, I.R. Chen, Anal. Chem. 66 (1994) 1473-1479.
9. E. Tesarova, K. Zaruba, M. Flieger, J. Chromatogr. A 844 (1999) 137-144.
10. T.J. Ward, A.B. Farris, J. Chromatogr. A 806 (2001) 73-79.
11. H.Y. Aboul-Enein, I. Ali, J. Liq. Chromatogr. Rel. Tech. 25 (2002) 2337-2344.
12. A.G. Goodman, L.S. Gilman, T.W. Rall, F. Murad (Eds.), Goodman and Gilman's, the Pharmacologica Basis of Therapeutics, seventh ed, Macmillan, New York, 1985, p. 487.
13. N.G. Bowery, Trends Pharmacol. Sci. 4 (1982) 400-407.
14. D.R. Hill, N.G. Bowery, Nature 290 (1981) 149-156.
15. H.R. Olpe, H. Dermie Ville, V. Baltzer, W.L. Bencze, W.P. Koella, P. Wolf, H.L. Hass, Eur. J. Pharm. 52 (1978) 133-139.
16. M.T. Chiang, S.Y. Chang, C.W. Whang, J. Chrmatogr. A 877 (2000) 233-237.
17. P.M. Harrison, A.M. Tonkin, A.J. Mclean, J. Chromatogr. Biomed. Appl. 40 (1985) 424-428.
18. A.M. Rustum, J. Chromatogr. Biomed. Appl. 79 (1989) 107-115.
19. M. Flardh, B.M. Jacobson, J. Chromatogr. A 846 (1999) 169-173.
20. E.W. Wuis, R.J.M. Dirks, T.B. Vree, E.V. Kleyn, J. Chromatogr. 337 (1985) 341-345.
21. S. Tosunoglu, L. Ersoy, Analyst 120 (1995) 373-375.
22. L. Millerioux, M. Brault, V. Gualano, A. Mignot, J. Chromatogr. A 729 (1996) 309-314.
23. C. Vaccher, P. Berthelot, M. Debaert, J. Chromatogr. 645 (1993) 95-101.
24. H. Spahn, D. Krauss, E. Mutschler, Pharm. Res. 5 (1988) 107-112.
25. A. Sioufi, G. Kaiser, F. Lerous, J.P. Dubois, J. Chromatogr. 450 (1988) 221-227.
26. Z. Zhu, L. Neirinck, J. Chromatogr. B 785 (2003) 277-283.
27. K.M. Fried, P. Koch, I.W. Wainer, Chirality 10 (1998) 484-489.
28. W.J. Lough, I.W. Wainer (Eds.), High Performance Liquid Chromatography: Method Development and Quantitation, Blakie Academic and Professional, Glasgow, UK, 1996, pp. 160-161.